Large technological and pharmaceutical companies accelerate the application of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their cooperation to accelerate The development and development of AI healthcare tools. Ge Healthcare worked with AWS to build Genetics AI for medical use in 2024.
Now, a Thai -based healthcare start, HDIt has created a market, HDMall, to digitize the fragmented medical industry in Southeast Asia. Starting helps users find healthcare providers such as hospitals and clinics. It also helps people find specific surgery and health controls, accumulate services to reduce costs and provide users with dose payment options.
The start has secured funding of $ 7.8 million to boost its market and further invest in AI technology. Recent funding marks the first investment of the US pharmacy Giant Merck Sharp & Dohme (MSD) at a HealthTech start -up in Asia -Pacific. (MSD is the brand used by Merck to operate outside the US and Canada and that Started a accelerator called Idea Studios Last June.) Other HD funding included SBI Ven Capital, M Venture Partners, Febe Venture and Parech Partners also participated in the latest funding.
“MSD, which produces HPV vaccines, reached the [us] Because we had already sold a lot of HPV online vaccines given to hospitals and clinics we work with, “said Co -founder and CEO of HD Sheji Ho in an exclusive interview with TechCrunch.” And if you look at the numbers, we [offer] The largest number for vaccines online in the markets. ”
The five -year starting market has more than 30,000 stocks of stocks (SKUs) from more than 2,500 hospitals and clinics and a handful of pharmaceutical partners and 400,000 customers paying in Thailand and Indonesia, creating $ 100 million in annual volumes . Its purpose is to reach 5,000 healthcare providers and 600,000 patients in 2025.
The latest funding, which brings HD’s total funding to $ 18 million, comes less than a year after a $ 5.6 million tour.
In early 2024, HD began manufacturing an AI Chatbot, JIB AI, which has been trained in anonymous healthcare data, trading data and Commerce Commerce data using advanced large linguistic models. Following the application of AI genetic technology on its market, almost 60% of customer interactions are managed by AI agents, who provide “high quality, immediate 24/7 response to customers,” Ho said.
Jib AI helps health professionals such as nurses, doctors and surgeons focusing on providing quality patient care by handling most of the initial navigation and care.
During the next 12 months, the company aims to improve AI Agent’s capabilities by adding the processing of orders and refund, assisted funds, planning, electronic health control and medical information with Jib AI health assistant and through AI -Powered Asynchronous Virtual Care with special doctors.
The start states that it plans to expand the external partners’ network over the next two years, focusing on insurance and pharmaceutical companies, as well as employers and educational institutions.
“While US healthcare companies such as Transcarent and Accolade A ‘B2C2B Strategy’ as defined by Andreessen Horowitz“Ho said TechCrunch.” This approach utilizes B2C’s existing success to transition to B2B, effectively pursuing the revenue of revenue from scratch. “
Health Care in Southeast Asia
Most healthcare businesses supported by the business in Southeast Asia, including Singapore’s doctor anywhere, Halodoc and Aldokter in Indonesia, focus mainly on Telehealth and Virtual Health services. But Ho says that the approach is not viable in Southeast Asia. “The post-literal, Telehealth as a business model at sea has faced significant challenges and quickly loses favor both consumers and investors.”
The company is now placed as Amazon One Medical mixture in the US, Chinese Health Care Platforms Health jd and Health alibabaand the Indian healthcare platform Pristyn care.
The healthcare industry is quite different in the emerging markets of Southeast Asia such as Thailand, Indonesia and Vietnam. Without a family doctor system such as western countries, patients often go straight to hospitals or clinics. This makes it difficult for patients to find the right health care services, to know where to go and understand how to handle costs, Ho told TechCrunch.
Due to 40% of health care expenditure paid by individuals and low levels of private health insurance, people are more sensitive to prices and feel more pressure when making decisions. This leads to a growing demand for platforms that offer clarity, transparency and ease of comparison between various providers, Ho continued.
The HD platform works more like “Amazon of Healthcare”. Instead of recording individual GPS or providing planning for a doctor’s appointment, it allows healthcare providers to sell productive services. “Our offers range from health controls, cancer projections and IVF procedures in root channel treatments, HPV vaccinations and surgeries such as thyroid and hemorrhoid surgeries. They start healthcare travel – looking for specific services and not individual doctors, “Ho said.
HD provides its services in Thailand and Indonesia and plans to enter Vietnam and Eye Myanmar due to similar healthcare systems.
“Their health care model is quite similar to some ways in mainland China. So it is a high cash payment, about 40%. There is no family doctor system, so people go straight to hospitals or clinics. Insurance comes into the game, “Ho told TechCrunch. “But these budgets become smaller and smaller. This means that more than pressure to cover health care is shifted to the private sector, whether it is cash or private insurance. That is why insurance promotes a Great opportunity for us. “
In addition, there is an increasing tendency towards self-empowerment in terms of users’ behavior in these markets. They become more common in using tools such as Google Search or Chatgpt to look for health -related issues. This is well aligned with what HD provides, as it enables people to make their own healthcare choices, according to Ho.
